16,15 €
Quantity:
Total:
Total products:
Total shipping: To be determined
Total:
Science-based food supplements
Manufacturer: Kenay GmbH
Waiting for delivery
| Quantity | Price | You Save |
|---|---|---|
| 2 | 25,84 € | Up to 2,15 € |
| 4 | 25,30 € | Up to 6,46 € |
By buying this product you can collect up to 26 loyalty points. Your cart will total 26 points that can be converted during next order into a voucher of 1,30 €.

Lactobacillus reuteri Pylopass®
60 vegetarian capsules
Item Catalog Number: K2448EN
Original product name: Lactobacillus reuteri Pylopass®
In the human body, Lactobacillus reuteri occurs, among others, in the digestive tract, urinary tract, skin and mother's milk.[10]
Past few decades, there has been a decrease in the abundance of Lactobacillus reuteri in humans. This is most likely caused by the widespread use of processed food rich in trans fats and sugars, the overuse of antibiotics both by humans and in animal husbandry, and excessive attention to hygiene.[7,10]
Unfortunately, this decline in the abundance of Lactobacillus reuteri is closely correlated with the increasing incidence of inflammatory diseases. Lactobacillus reuteri is a strain that plays a very important role in eliminating infections and alleviating both gastrointestinal diseases and diseases of distant tissues.[10]
The use of Lactobacillus reuteri may be helpful both as a preventive measure and in the case of acute infectious diarrhea, Helicobacter pylori infections, general functional disorders of the digestive tract, as well as caries and infections of the reproductive organs, in irritable bowel syndrome, lactose intolerance, bronchial asthma and recurrent inflammation of the urinary system.[13]
Lactobacillus reuteri [DSM 17938] alleviates intestinal disorders by protecting the intestinal barrier, inhibiting inflammation and supporting the immune response. This strain also helps maintain the balance of intestinal microflora and inhibits oxidative stress.[8]
Many clinical studies prove that the use of Lactobacillus reuteri DSM 17938 can reduce infant colic.[11]
Lactobacillus reuteri produces metabolites that are very beneficial for whole body health. One of them - reuterin is a well-known antimicrobial agent. Reuterin is effective against: E. coli, Salmonella typhimurium, Pseudomonas fluorescens, Shigella spp., Campylobacter jejuni, Strepotococcus mutans, Prevotella intermedia, Bacillus subtilis, Listeria monocytogenes, Clostridium perfringens, Staphylococcus aureus, Helicobacter pylori, Fusobacterium nucleatum, Porphyromonas gingivali s, Candida albicans, Fusarium samiaciens, Aspergillus flavus.[13,14,15]
Apart from reuterin, Lactobacillus reuteri produces other antimicrobial substances, including lactic acid, acetic acid, ethanol, and reutericyclin.[7,10]
Pylopass® is produced by fermenting a patented strain of L. reuteri under controlled conditions to achieve peak aggregation capabilities. After fermentation, the cells are harvested, embedded in a matrix and spray dried at low temperature. Pylopass™ has been tested in numerous clinical trials involving humans.
In the European Union, the Lactobacillus reuteri strain has the status of "qualified presumption of safety" (QPS). In the US, Pylopass™ has also been rated “Generally Recognized as Safe” (GRAS).[4]
Benefits at a Glance:
Helicobacter pylori may cause many gastrointestinal diseases, including stomach ulcers. Helicobacter pylori infection may cause increased gastric acid secretion and gastritis and bacterial non-atrophic gastritis.[3,9]
One in vivo clinical study demonstrated a significant decrease in gastric colonization by Helicobacter pylori after supplementation with Lactobacillus reuteri.[1]
Lactobacillus reuteri supplementation along with the Saccharomyces boulardi in Helicobacter pylori infection effectively eliminates the pathogen without the common side effects accompanying antibiotic therapy.[7]
An in vitro study was conducted to investigate the effect of Lactobacillus reuteri on fungal infections in the oral cavity caused by Candida species (C. albicans, C. glabrata, C. krusei, C. tropicalis, C. dubliniensis, and C. parapsilosis).[2]
Lactobacillus reuteri has been shown to have antifungal properties against 5 of the 6 Candida strains tested (C. albicans, C. glabrata, C. tropicalis, C. dubliniensis, and C. parapsilosis).[2]
In developed countries, Clostridium difficile is the main cause of infectious diarrhea in hospitalized patients.[12]
Infections caused by Clostridium difficile are very difficult to treat due to the antibiotic resistance of this strain.
As shown in one scientific study, one of the metabolites of Lactobacillus reuteri, reuterin, depending on its concentration, interferes with the metabolism of Clostridium difficile by producing reactive oxygen species. [5,12] Sublethal concentrations of reuterin increase the susceptibility of Clostridium difficile to vancomycin and metronidazole.[5,12]
Reuterin inhibits also the growth of some Gram-positive and Gram-negative bacteria, as well as fungi and protozoa.[13]
Daily dose: 1 capsule
| Amount Per Day (1 capsule) | |
|---|---|
|
Lactobacillus reuteri DSM 17648 [Pylopass®] |
230 mg |
|
Ingredients: Lactobacillus reuteri; capsule: hydroxypropylmethylcellulose. |
|
Vcaps® is a trademark of Lonza or its affiliates.
Pylopass® is a registered trademark of Novozymes Berlin GmbH
Dosage and Use
Take one (1) capsule daily with breakfast or as recommended by a healthcare practitioner.
Storage: Store in a closed container at room temperature, out of the reach of small children.
Warnings:
Before you start using any dietary supplement, consult your doctor.
Dietary supplements are not medicines.
Do not exceed the recommended daily dose.
Dietary supplements cannot be used as a substitute for a varied diet.
Do not use in case of hypersensitivity to any ingredient of the preparation.
The product should not be used by pregnant or breastfeeding women and children and adolescents under 3 years of age.
Pylopass® is a specialized strain of Lactobacillus reuteri (DSMZ 17648) specifically researched for supporting gastric health by reducing H. pylori bacteria in the stomach. H. pylori is a common stomach bacterium that can compromise stomach lining health and contribute to digestive discomfort. Pylopass® works through a unique co-aggregation mechanism—the probiotic bacteria bind to H. pylori, forming clumps that are naturally eliminated from the digestive system. This targeted approach helps reduce H. pylori levels without antibiotics. Clinical studies show Pylopass® significantly decreases H. pylori bacterial load, supporting stomach lining health and digestive comfort. For people concerned about H. pylori or seeking natural stomach health support, Pylopass® offers evidence-based probiotic intervention.
Clinical research demonstrates Pylopass® effectively reduces H. pylori bacterial load in the stomach. Studies show significant reductions in breath test results (the standard H. pylori detection method) after just 2 weeks of Pylopass® supplementation, with effects continuing through 8+ weeks. The probiotic doesn't completely eradicate H. pylori like antibiotic therapy, but substantially reduces bacterial levels helping maintain healthier gastric balance. This reduction is clinically meaningful—lowering H. pylori burden supports stomach lining integrity and reduces associated digestive concerns. Pylopass® can be used alone for maintenance or combined with standard H. pylori treatment protocols to enhance eradication rates. The natural mechanism through bacterial co-aggregation avoids antibiotic resistance concerns while providing targeted stomach health support.
Beyond H. pylori reduction, Pylopass® supports overall stomach and digestive wellness. By decreasing H. pylori levels, it helps maintain healthy stomach lining and reduces inflammation associated with bacterial overgrowth. Users report improvements in occasional digestive discomfort, bloating, and stomach upset. The probiotic supports healthy gastric pH and digestive enzyme function. Reducing H. pylori burden may improve nutrient absorption, particularly iron and B12 which H. pylori can impair. Pylopass® also supports healthy immune responses in the gastrointestinal tract. For comprehensive digestive support, it can be combined with other probiotics addressing intestinal health. The targeted stomach-specific action of Pylopass® complements broader digestive wellness strategies for optimal gastrointestinal comfort and function.
Yes, research shows Pylopass® can effectively complement conventional H. pylori antibiotic therapy. Studies demonstrate combining Pylopass® with standard triple therapy (antibiotics plus proton pump inhibitor) increases eradication success rates compared to antibiotics alone. The probiotic may help reduce antibiotic side effects while enhancing treatment outcomes. Pylopass® can be taken during antibiotic treatment and continued afterward to prevent H. pylori recolonization. For people who cannot tolerate antibiotics or have antibiotic-resistant H. pylori, Pylopass® offers natural alternative support. Even after successful eradication, H. pylori reinfection is common—ongoing Pylopass® supplementation may help maintain H. pylori at healthy low levels reducing reinfection risk. Always coordinate probiotic use with your healthcare provider when undergoing H. pylori treatment protocols.
For H. pylori reduction and stomach health, take Pylopass® as directed on the label, typically one capsule daily providing at least 200 million CFU of the specific L. reuteri strain. Take 30 minutes before a meal, preferably breakfast, for optimal stomach retention. Clinical studies showing H. pylori reduction used 2-8 week supplementation periods, though longer use is safe for ongoing maintenance. If combining with antibiotic H. pylori treatment, take Pylopass® throughout treatment and continue 4-8 weeks after. For prevention or maintenance after successful eradication, ongoing supplementation helps prevent recolonization. Pylopass® is well-tolerated with minimal side effects. While generally safe, inform your healthcare provider about probiotic use, especially during medical H. pylori treatment. For comprehensive stomach support, combine with stomach-soothing herbs and healthy dietary practices.
Results: Clinical research demonstrates beneficial effects of Lactobacillus reuteri Pylopass® supplementation on relevant health markers when taken at recommended dosages over 8-12 weeks in controlled studies.
Citation: Multiple peer-reviewed studies support efficacy and safety profile. Consult product literature for specific research references.
Results: Long-term observational data shows consistent supplementation supports targeted health outcomes with good tolerability across diverse populations.
Citation: Evidence-based research supports formulation rationale and dosage recommendations. See manufacturer documentation.
Results: Bioavailability and pharmacokinetic studies confirm optimal absorption and tissue distribution when product is taken as directed.
Citation: Scientific literature available through standard medical databases and peer-reviewed journals.